TRPC4 inactivation confers a survival benefit in severe pulmonary arterial hypertension.
Alzoubi A, Almalouf P, Toba M, O'Neill K, Qian X, Francis M, Taylor MS, Alexeyev M, McMurtry IF, Oka M, Stevens T.
Alzoubi A, et al. Among authors: qian x.
Am J Pathol. 2013 Dec;183(6):1779-1788. doi: 10.1016/j.ajpath.2013.08.016. Epub 2013 Oct 8.
Am J Pathol. 2013.
PMID: 24113457
Free PMC article.